The FDA has warned that Mommy's Bliss Nipple Cream contains potentially harmful ingredients that may cause respiratory distress or vomiting and diarrhea in infants. The ingredients in this cream are: chlorphenesin and phenoxyethanol. Chlorphenesin relaxes skeletal muscle and can depress the central nervous system and cause respiratory depression (slow or shallow breathing) in infants.

THURSDAY, May 15 (HealthDay News) -- PhotoMedex's XTRAC Velocity Laser has been approved by the U.S. Food and Drug Administration to treat psoriasis and other skin disorders, including vitiligo, atopic dermatitis and leukoderma, the company said Thursday.

The new system delivers higher UV power and is up to three times faster than its predecessor, PhotoMedex said in a statement.

By Serena Gordon
EmpowHer's HealthDay Reporter

WEDNESDAY, May 14 (HealthDay News) -- A commonly used migraine medication may cause so-called serotonin syndrome in rare cases, new research suggests.

By Steven Reinberg
EmpowHer's HealthDay Reporter

WEDNESDAY, May 14 (HealthDay News) -- A new Canadian study confirms that people given Trasylol, a drug used to reduce bleeding during heart surgery, increases their risk of death by 53 percent.

The Ortho-Evra birth control patch exposes women to dangerous levels of estrogen -- posing a possible two-fold increased risk of blood clots -- and should be removed from the market within six months, says a Public Citizen petition filed Thursday with the U.S. Food and Drug Administration.

By Alan Mozes
EmpowHer's HealthDay Reporter

WEDNESDAY, May 7 (HealthDay News) -- Older adults following a medication regimen are less likely to miss doses when reminded by an electronic pillbox that both beeps at the appointed drug-taking time and announces the number of pills to take and how to take them, new research reveals.

WEDNESDAY, May 7 (HealthDay News) -- A new class of weight-loss drugs that suppresses appetite by blocking cannabinoid receptors in the brain should be used with caution in children, U.S. scientists report.

Between 1996 and 2005, there were 13 deaths and more than 1,500 injuries reported among young people using insulin pumps to treat type 1 diabetes, says a U.S. Food and Drug Administration study. The pumps offer an alternative to multiple daily injections of insulin by syringe.

CHICAGO - Insulin pumps are used by tens of thousands of teenagers worldwide with Type 1 diabetes, but they can be risky and have been linked to injuries and even deaths, a review by federal regulators finds.

Parents should be vigilant in watching their children’s use of the pumps, researchers from the Food and Drug Administration wrote. They didn’t advise against using the devices. But they called for more study to address safety concerns in teens and even younger children who use the popular pumps.

Read full story

A new version of the painkiller OxyContin, designed to be harder to abuse, will be evaluated Monday by a U.S. Food and Drug Administration advisory panel to determine if the reformulated version should be allowed on the market before long-term studies determine if it actually reduces abuse.